Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Journal of Molecular Recognition : JMR|January 21, 2004
Immunomodulation by the copolymer glatiramer acetateRuth Arnon, Michael SelaJournal of Autoimmunity|March 31, 2009
The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's diseaseEirik Bratland, Geir Bredholt, Gunnar Mellgren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 29, 2015
Cancer Immunotherapy: More Is (Much) BetterYosef Yarden, Michael SelaClinical Immunology (Orlando, Fla.)|November 1, 2005
Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinaseMicha J Rapoport, Amir Sharabi, Dorit Aharoni, et al.Human Immunology|March 13, 2009
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patientsZev M Sthoeger, Amir Sharabi, Molly Dayan, et al.Journal of Autoimmunity|April 7, 2009
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expressionZev M Sthoeger, Amir Sharabi, Yair Molad, et al.Clinical Immunology (Orlando, Fla.)|May 7, 2018
The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patientsZev Sthoeger, Amir Sharabi, Ilan Asher, et al.Methods in Molecular Biology (Clifton, N.J.)|June 15, 2015
Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor TherapyGeorg Mahlknecht, Michael Sela, Yosef YardenDrug Discovery Today|July 12, 2002
Therapeutic vaccines: realities of today and hopes for the futureMichael Sela, Ruth Arnon, Bilha SchechterPhysiology (Bethesda, Md.)|May 1, 2010
Roles for growth factors in cancer progressionEsther Witsch, Michael Sela, Yosef YardenPageof 9